Onconic Therapeutics Inc. (KOSDAQ:476060)
17,280
-1,800 (-9.43%)
At close: Dec 5, 2025
| Market Cap | 768.78B |
| Revenue (ttm) | 46.65B |
| Net Income (ttm) | 16.75B |
| Shares Out | 44.49M |
| EPS (ttm) | n/a |
| PE Ratio | 45.89 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,700,974 |
| Average Volume | 4,992,096 |
| Open | 19,380 |
| Previous Close | 19,080 |
| Day's Range | 16,800 - 19,800 |
| 52-Week Range | 3,138 - 26,600 |
| Beta | n/a |
| RSI | 51.36 |
| Earnings Date | Nov 11, 2025 |